Published in Metab Syndr Relat Disord on January 12, 2017
Cross Talk between Adipose Tissue and Placenta in Obese and Gestational Diabetes Mellitus Pregnancies via Exosomes. Front Endocrinol (Lausanne) (2017) 0.75
Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care (2002) 9.08
AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest (2006) 3.39
Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol (2013) 3.10
The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol (2010) 2.90
Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett (1994) 2.65
Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature (1995) 2.54
Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol (1999) 2.29
Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care (2008) 2.18
Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis In 3T3-L1 adipocytes. J Biol Chem (2003) 1.90
Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol (1991) 1.70
Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes (2000) 1.62
Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab (2002) 1.35
Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance. Diabetes (2005) 1.24
Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes (1999) 1.22
Disturbances in lipid metabolism in diabetic pregnancy - Are these the cause of the problem? Best Pract Res Clin Endocrinol Metab (2010) 1.22
Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf) (2012) 1.14
Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia. Am J Physiol Endocrinol Metab (2005) 1.14
Role of ENPP1 on adipocyte maturation. PLoS One (2007) 1.07
Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue. J Mol Endocrinol (2009) 1.03
Metabolic consequences of ENPP1 overexpression in adipose tissue. Am J Physiol Endocrinol Metab (2011) 1.00
Adipose tissue dysfunction in humans: a potential role for the transmembrane protein ENPP1. J Clin Endocrinol Metab (2012) 0.92
Free fatty acids, insulin resistance, and pregnancy. Curr Diab Rep (2003) 0.91
Maternal-fetal metabolic gene-gene interactions and risk of neural tube defects. Mol Genet Metab (2013) 0.88
Effect of pre-existing maternal obesity, gestational diabetes and adipokines on the expression of genes involved in lipid metabolism in adipose tissue. Metabolism (2013) 0.85
Adiponectin and IGFBP-1 in the development of gestational diabetes in obese mothers. BMJ Open Diabetes Res Care (2014) 0.83
Post-partum plasma C-peptide and ghrelin concentrations are predictive of type 2 diabetes in women with previous gestational diabetes mellitus. J Diabetes (2015) 0.79
Human adipose tissue expansion in pregnancy is impaired in gestational diabetes mellitus. Diabetologia (2015) 0.78
Serum levels of the adipokine Pref-1 in gestational diabetes mellitus. Cytokine (2014) 0.77